Last reviewed · How we verify
CRx-102
At a glance
| Generic name | CRx-102 |
|---|---|
| Also known as | Prednisolone plus dipyridamole |
| Sponsor | Zalicus |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in RA (PHASE2)
- Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis (PHASE2)
- CRx-102 Osteoarthritis Multicenter Evaluation Trial (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |